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Ectodermal dysplasias (ED) are characterized by impaired
development of organs forming from the embryonic sur-
f a c ee c t o d e r m .T h u s ,i nE Do r g a n sl i k et e e t h ,h a i r ,n a i l s
and exocrine glands are hypoplastic or totally missing. The
pathogenesis of the defects is starting to be understood
thanks to the identification of the responsible gene muta-
tions, and to the advances in developmental biology. Rapid
progress particularly in genetics and in the generation of
genetically modified animals such as transgenic mice has
allowed the exploration of events leading to ectodermal
organ defects at the cellular and molecular levels. Mouse
models have been produced for many different ED syn-
dromes. Most work so far has focused on hypohidrotic ED
which is caused by mutations affecting the ectodysplasin
(Eda) signalling pathway. Analyses of mouse mutants in
which Eda signalling is either blocked (like in most
patients with hypohidrotic ED) or overactivated have indi-
cated that Eda signalling is a key regulator of ectodermal
placodes. The placodes initiate the formation of ectoder-
mal organs, their positions determine the location of these
organs, and their size is associated with organ size. Eda
signalling also affects later stages of development, influen-
cing for instance the shape of teeth and branching of sali-
vary and mammary glands. Recent data indicate that Eda
signalling is intimately linked to many other signalling
pathways, e.g. Wnt, BMP, and FGF pathways, which regu-
late cell communication together with Eda. The detailed
understanding of the functions of these molecular net-
works can be expected to lead to new possibilities to pre-
vent and treat ED.
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